NCT02182271View on ClinicalTrials.gov

Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

BI 201335 ZW - single rising dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY